BioAtla, Inc.BCABNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-12.9%
5Y CAGR+12.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-12.9%/yr
vs +23.1%/yr prior
5Y CAGR
+12.4%/yr
Recent deceleration
Acceleration
-36.0pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$19.01M-13.0%
2024$21.85M-15.8%
2023$25.96M-9.9%
2022$28.79M-25.0%
2021$38.42M+262.6%
2020$10.60M+40.3%
2019$7.55M-39.9%
2018$12.56M-